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Intraductal papillary mucinous 
neoplasm (IPMN) 
Colloid carcinoma 
a b s t r a c t 
Colloid carcinomas are rare pancreatic tumors characterized by the presence of mucin pools 
with scarce malignant cells. Most of these neoplasms arise from intestinal-type intraductal 
papillary mucinous neoplasms (IPMNs). We report a case of a 77-year-old male patient who 
presented with weight loss, asthenia, lumbar pain and diabetes. Imaging studies revealed 
a mixed-type IPMN with high-risk features and a possible invasive component. The patient 
underwent surgical resection and the histology confirmed an invasive colloid carcinoma of 
the pancreas associated with an intestinal-type IPMN. Although invasive ductal and colloid 
carcinomas may look similar on imaging studies, its distinction is important because the 
latter have a better prognosis. 
© 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington. 
This is an open access article under the CC BY-NC-ND license 









Invasive carcinoma arising from intraductal papillary muci-
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Fig. 1 – Coronal (A) and axial (B) magnetic resonance T2-weighted images reveal a diffuse dilation of the main pancreatic 
duct (arrows), with hyperintense luminal content. Some associated cystic lesions are also seen throughout the pancreas. 
Fig. 2 – Magnetic resonance T1-weighted images with fat saturation before (A) and after extracellular gadolinium-chelate 
administration in portal venous phase (B) reveal an enhancing nodule in the neck of the pancreas (arrows). The same 
nodule shows restriction to diffusion, seen as high signal on high b-value diffusion weighted-image (C) and low signal on 






























A 77-year-old male patient presented with a 2-month his-
tory of weight loss, asthenia, lumbar pain, and new onset of
diabetes mellitus. Past medical history included abdominal
aneurysm, dyslipidemia, and high blood pressure. Moreover,
he reported a history of tobacco and alcohol abuse in the past.
Prior workup on another institution included a
colonoscopy to exclude colorectal cancer and an abdom-
inal computed tomography (CT). The abdominal CT raised
suspicion of an IPMN with a solid component in the head of
the pancreas. 
The biochemical evaluation revealed normal liver func-
tion tests and a normal level of Carbohydrate Antigen 19-
9 (CA 19-9) (17 U/mL for a normal < 37 U/mL). The levels of
carcinoembryonic antigen (CEA) were increased (6.5 ng/mL;
normal < 2.5 ng/mL). To better characterize those findings, the patient under-
went magnetic resonance cholangiopancreatography (MRCP).
The MRCP revealed several pancreatic cystic lesions in asso-
ciation with a diffuse dilatation of the main pancreatic duct
(up to 18 mm in diameter), which was filled with hyperin-
tense content on T2-weighted images ( Fig. 1 ). Some enhanc-
ing solid mural nodules were seen along the main pancreatic
duct in the pancreas head and body, with restriction to diffu-
sion ( Fig. 2 ). These findings are in accordance with a mixed-
type IPMN with high-risk features and a likely invasive com-
ponent. The cystic mass contacted the first part of the duo-
denum, the intra-pancreatic portion of the common bile duct,
and the gastric antrum. There were no liver metastasis, peri-
toneal nodules, or ascitis. 
Total pancreatectomy with splenectomy and distal gas-
trectomy was performed, to achieve negative surgical mar-
gins. The postoperative period was uneventful. 
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Fig. 3 – Histopathological findings. (A) Gross images of sequential sections of the resected specimen at the pancreatic head 
level showing pancreatic cysts (arrows) and dilation of the main pancreatic duct. (B and C) Histological analysis reveal large 
mucin pools with scarce malignant cells, some arranged into small groups (arrowhead), findings that are typical of colloid 
carcinoma (Hematoxylin and Eosin [H&E], scale bar corresponds to 100 μm [B] and 200 μm [C]). (D) Other tumor areas 
showed isolated malignant cells floating inside the mucinous lakes (H&E, scale bar corresponds to 50 μm). (E) Associated 
intestinal-type IPMN with low-grade (white arrow) to high-grade dysplasia (black arrow) (H&E, scale bar corresponds 
to 100 μm). IPMN, intraductal papillary mucinous neoplasm. 
Fig. 4 – Intestinal-type IPMN: immunohistochemical staining show that the neoplastic cells display expression for the 
markers CK7, CK20, CDX-2, MUC2, and MUC5AC (scale bar corresponds to 1 mm). H&E, Hematoxylin and Eosin; CK, 












The histologic examination revealed an invasive colloid
carcinoma in the pancreas head and body, measuring more
than 40 mm, associated with an intestinal mixed-type IPMN
( Figs. 3 and 4 ). There was high-grade dysplasia in the main
pancreatic duct. The circumferential margins of resection
were negative, and all the lymph nodes were negative for ma-
lignant cells. Furthermore, there was no perineural or lympho-
vascular invasion. Discussion 
IPMNs are mucin-producing exocrine pancreatic neoplasms.
According to the anatomic ductal involvement, they can be
classified into main duct, side branch, and mixed type [ 1 ,3 ]. 
On the other hand, according to their histological features,
IPMNs are divided into 4 subtypes: gastric, intestinal, pan-









































creatobiliary, and oncocytic [ 1 ,4 ], each with different malig-
nant potential, the pancreatobiliary type being the one with
a higher risk of malignancy [4] . 
Features that suggest malignancy of an IPMN are jaundice,
a solid component or enhancing mural node(s) measuring 5
mm or more, a main pancreatic duct dilation of 10 mm or
more, and cystic lesions measuring more than 3 cm in size
[ 4 ,5 ]. 
Most of the invasive carcinomas arising from IPMN are
ductal (tubular) carcinomas, resembling classic ductal adeno-
carcinoma. Nevertheless, a smaller number are colloid car-
cinomas, mixed or anaplastic tumors. Colloid carcinoma or
mucinous noncystic carcinoma represents 1%-3% of all inva-
sive pancreatic adenocarcinomas [6] . Typically, colloid carci-
nomas arise from intestinal-type IPMNs [ 1 ,7 ], whereas tubu-
lar carcinomas arise from pancreatobiliary and gastric types
IPMNs [1] . 
Histologically, colloid carcinomas are characterized by ex-
tracellular mucin lakes with sparse malignant cells [ 6 ,8 ]. Due
to their origin, they express the intestinal markers MUC2 and
CDX2 [7] . 
Colloid carcinomas have a better prognosis than tubular
carcinomas [1] . Its 5-year survival rate is estimated to be 57%,
whereas that of tubular carcinomas is 12% [8] . 
IPMN-associated tubular and colloid carcinomas may look
identical in imaging studies. Fouladi et al. [1] recently reviewed
the role of some CT features to distinguish colloid from tubu-
lar carcinomas. A sudden caliper change of the main pancre-
atic duct associated with a solid mass that does not commu-
nicate with the duct is the most accurate sign to differenti-
ate those tumors, suggesting a tubular carcinoma. Conversely,
cystic masses communicating with the main pancreatic duct
are more likely to represent colloid carcinomas. 
Surgical treatment of main-duct and mixed IPMNs with
worrisome features must be considered in all patients fit for
surgery [5] . There are no established guidelines to specifically
address the adjuvant treatment of resected invasive colloid
carcinomas [ 1 ,3 ]. Adjuvant chemotherapy may improve sur-
vival in patients with tubular carcinomas but not in those with
colloid carcinomas [7] . 
Long-term surveillance is required after resection of inva-
sive IPMNs to detect a possible recurrence [3] . The disease-free of survival of recurrent resected IPMN-associated invasive
neoplasms is of 29 months [5] . 
Patient consent 
The authors obtained written informed from the patient for
publication of this case report. 
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